Abstract
Twenty-four week decline in forced vital capacity (FVC) predicts mortality at week 52 in the INPULSIS trials
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have